The future of digital health part 3: AI, machine learning and robotics

Part 3

This post is part three of a new series featuring healthcare visionary and thought leader Andy Dé. In this series, Dé discusses how COVID-19 has triggered remarkable digital transformation and uncovers five, long-term innovation implications that providers, healthcare leaders, and payers need to consider.

The past two weeks, Dé led us through the first two implications (you can catch up part 1 and part 2 ), and today he dives into today he dives into numbers three and four.


Innovation implication #3: Artificial intelligence and machine learning for operations, revenue cycle and supply change management innovation

There is a growing need to enable advanced predictive, prescriptive and spatial analytics to empower executives, line of business (LOB) leaders, clinicians and nurses at the point of care. As a result, we’re seeing a convergence of AI (machine learning, deep learning, natural language processing) and descriptive and spatial analytics with actionable, forward looking insights to power critical decisions.

I predict health systems and hospitals leveraging these advanced technologies and analytics for operations, revenue cycle and supply chain innovation to:

  • Locate and design new facilities, testing centers and supply chain warehouses
    • Optimizes access to care and convenience for patients and their families
    • Expands capacity for cardiovascular procedures, hip and knee replacements, cancer care and more, with the ability to align capacity with demand
  • Optimize supply chain network (especially for overseas suppliers)
    • Enables accurate and reliable demand forecasts
    • Supports potential partnerships with Emergency Response Inventory Services Providers to ensure ample supply of N-95 masks, PPE, ventilators, testing equipment and supplies, critical therapeutics and vaccines, and medical devices and equipment
  • Forecast demand for elective procedures and services from their patient population
    • Leverages clinical, financial and socio-economic determinants of health data
    • Accounts for hospital and provider capacity, as well as profitability from a revenue and margin perspective
    • Prioritizes treatment and services at hospital locations aligned with that demand for optimal patient access

Innovation implication #4: Medical robotics

I expect visionary leaders at top healthcare organizations and health systems to embark on a journey to embrace medical robotics. Robotics can enable process automation and higher efficiencies while assuring safety for healthcare personnel and front-line workers.

The framework below shows four primary areas and corresponding applications that are already being enabled by robotics – and will continue to be developed and explored in the post-pandemic era.

Countries including Japan, China, South Korea, and Taiwan are already testing the use of multiple applications ranging from improvement of manual process efficiency to protection of care teams through non-contact diagnosis enablement and support of clinical procedures to enabling post-discharge patient care and recovery.

That wraps up our dive into AI, machine learning, and robotics. Tune in next week for our fifth and final innovation implication: convergence of AI and analytics for healthcare payers. If you have any questions about what I’ve covered in this series so far, don’t hesitate to reach out.

Andy Dé

Andy Dé is the Chief Marketing Officer. Andy joined MedeAnalytics in March 2021 bringing more than 20 years of enterprise software product marketing, product management and industry strategy experience. In his role, Andy oversees the company’s go-to-market (GTM) strategy and marketing. He is passionate about healthcare innovation and is recognized as an industry thought leader in healthcare.

Get our take on industry trends

Providers: Are you ready to be audited?

February 15, 2022

By Donna Kennedy In 2020, regular audits conducted by CMS and other payers were paused or significantly reduced as the…

Read on...

From Insights to Action – The Digital Transformation of Healthcare in the Post-Pandemic “New Normal”

February 10, 2022

In November, MedeAnalytics hosted the 2021 Impact Summit, an engaging and educational event held annually and designed exclusively for our…

Read on...
From Insights to Action – The Digital Transformation of Healthcare in the Post-Pandemic “New Normal”

2022 Rx: Your new, post-pandemic prescription for success

January 11, 2022

By Dave Schweppe, Chief Analytics Officer, MedeAnalytics Despite the common use of the term “post-COVID,” most leaders across the healthcare…

Read on...
Combating the opioid epidemic photo

Combating the opioid epidemic in North America with Nobel Prize winning research

October 12, 2021

American Researchers Dr. David Julius and Dr. Ardem Patapoutian from California were awarded the Nobel Prize in medicine for their path breaking work on the development of non-opioid painkillers, showing immense promise for combating the epidemic.

Read on...